COM:CALIDIBIO
Calidi Biotherapeutics
- Stock
Last Close
2.15
22/11 21:00
Market Cap
37.48M
Beta: -
Volume Today
1.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -823.29K - | 4.29M 621.49% | 1.46M 65.94% | 4.16M 184.59% | 493.57K 88.14% | -2.59M 624.09% | -2.22M 14.00% | -4.27M 91.88% | -2.02M 52.58% | -8.23M 306.57% | -7.22M 12.20% | |
depreciation and amortization | 68K - | 91K 33.82% | 183K 101.10% | 100K - | 364K 264% | 374K 2.75% | ||||||
deferred income tax | ||||||||||||
stock based compensation | 1.06M - | 1.06M 0.38% | 1.43M 35.54% | 1.19M - | 888K 25.13% | |||||||
change in working capital | -1.36M - | 1.11M 181.28% | 63.73K 94.25% | 92.94K 45.85% | 574.69K 518.33% | 2.53M 340.26% | 1.86M 26.44% | 1.46M 21.47% | -12.55M 958.82% | 2.99M 123.80% | 1.92M 35.84% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | 62K - | 21K 66.13% | 1.49M - | 968K 34.81% | ||||||||
other working capital | -1.36M - | 1.05M 176.60% | 63.73K 93.90% | 92.94K 45.85% | 574.69K 518.33% | 2.54M 342.63% | 1.86M 26.84% | 1.46M 21.47% | -12.55M 958.82% | 9.16M 172.96% | 949K 89.64% | |
other non cash items | 718.08K - | -4.90M 781.93% | -1.99M 59.34% | -4.52M 127.16% | -1.40M 69.01% | 1.22M 187.17% | 555.70K 54.52% | 3.19M 473.74% | -7.69M 341.32% | 419.00K 105.45% | 883K 110.74% | |
net cash provided by operating activities | -1.47M - | 505.44K 134.39% | -465.13K 192.02% | -268.68K 42.24% | -333.27K 24.04% | 1.17M 449.60% | 192.29K 83.50% | 381.50K 98.40% | -22.37M 5,963.95% | -5.19M 76.82% | -3.83M 26.13% | |
investments in property plant and equipment | -67K - | -161K 140.30% | -137K 14.91% | -515K - | -70K 86.41% | -5K 92.86% | ||||||
acquisitions net | ||||||||||||
purchases of investments | -2.32M - | -425.85K 81.68% | -916.75K 115.27% | 1.34M 246.45% | ||||||||
sales maturities of investments | 190.01M - | 622.29K - | -622.29K 200% | |||||||||
other investing activites | 189.59M - | -189.59M 200% | 72K - | 35K 51.39% | ||||||||
net cash used for investing activites | -230M - | 189.59M - | -1.91M 101.01% | -425.85K 77.69% | -294.46K 30.85% | 277.31K 194.18% | -35K 112.62% | -5K 85.71% | ||||
debt repayment | -188.80K - | -460K - | -797.50K 73.37% | -222.50K 72.10% | -500K 124.72% | -978.50K 95.70% | -802K 18.04% | -3.04M 278.55% | ||||
common stock issued | 235.10M - | -2.34M 100.99% | -190.01M - | 30.30M - | ||||||||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | -2.34M - | 1.69M 172.59% | 4.26M - | 2.84M 33.35% | 1.28M 55.00% | -660K - | -162K 75.45% | |||||
net cash used provided by financing activities | 232.57M - | -640.13K 100.28% | -189.55M - | 797.50K 100.42% | 222.50K 72.10% | 500K 124.72% | 31.28M 6,155.90% | -2.96M 109.46% | 3.01M 201.86% | |||
effect of forex changes on cash | -18K - | 8K 144.44% | -19K - | 17K 189.47% | ||||||||
net change in cash | 1.10M - | -134.69K 112.22% | -465.13K 245.34% | -268.68K 42.24% | -288.90K 7.53% | 53.95K 118.67% | -11.06K 120.51% | 587.04K 5,405.85% | 9.58M 1,531.43% | -8.20M 185.60% | -806K 90.17% | |
cash at beginning of period | 95K - | 1.20M 1,160.36% | 1.06M 11.25% | 597.52K 43.77% | 328.84K 44.97% | 39.94K 87.85% | 93.89K 135.06% | 82.83K 11.78% | 669.87K 708.74% | 10.25M 1,429.71% | 2.05M 80.00% | |
cash at end of period | 1.20M - | 1.06M 11.25% | 597.52K 43.77% | 328.84K 44.97% | 39.94K 87.85% | 93.89K 135.06% | 82.83K 11.78% | 669.87K 708.74% | 10.25M 1,429.71% | 2.05M 80.00% | 1.24M 39.34% | |
operating cash flow | -1.47M - | 505.44K 134.39% | -465.13K 192.02% | -268.68K 42.24% | -333.27K 24.04% | 1.17M 449.60% | 192.29K 83.50% | 381.50K 98.40% | -22.37M 5,963.95% | -5.19M 76.82% | -3.83M 26.13% | |
capital expenditure | -67K - | -161K 140.30% | -137K 14.91% | -515K - | -70K 86.41% | -5K 92.86% | ||||||
free cash flow | -1.47M - | 505.44K 134.39% | -465.13K 192.02% | -268.68K 42.24% | -400.27K 48.98% | 1.00M 350.86% | 55.29K 94.49% | 381.50K 590.04% | -22.89M 6,098.94% | -5.26M 77.03% | -3.84M 27.02% |
All numbers in (except ratios and percentages)